Pharem
Martin Ryen currently serves as the CEO at Pharem since January 2013 and as the Chief Executive Officer at pCure since November 2020. Prior to these positions, Martin worked as a Research Engineer at SweTree Technologies AB from June 2011 to January 2013. Martin earned a MSc in Molecular Biotechnology from Uppsala University, completing their degree from 2005 to 2011.
Pharem
Pharem Biotech uses its broad biotechnology expertise to develop innovative enzymatic products that provide an effective way of removing organic pollutants in water environments. The products are specifically developed to meet customer needs of a simple and efficient solution to tackle serious environmental challanges within their scope of operation.